Correlation Between Mereo BioPharma and Kymera Therapeutics
Can any of the company-specific risk be diversified away by investing in both Mereo BioPharma and Kymera Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Mereo BioPharma and Kymera Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Mereo BioPharma Group and Kymera Therapeutics, you can compare the effects of market volatilities on Mereo BioPharma and Kymera Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Mereo BioPharma with a short position of Kymera Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Mereo BioPharma and Kymera Therapeutics.
Diversification Opportunities for Mereo BioPharma and Kymera Therapeutics
0.16 | Correlation Coefficient |
Average diversification
The 3 months correlation between Mereo and Kymera is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Mereo BioPharma Group and Kymera Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kymera Therapeutics and Mereo BioPharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Mereo BioPharma Group are associated (or correlated) with Kymera Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kymera Therapeutics has no effect on the direction of Mereo BioPharma i.e., Mereo BioPharma and Kymera Therapeutics go up and down completely randomly.
Pair Corralation between Mereo BioPharma and Kymera Therapeutics
Given the investment horizon of 90 days Mereo BioPharma Group is expected to under-perform the Kymera Therapeutics. In addition to that, Mereo BioPharma is 1.15 times more volatile than Kymera Therapeutics. It trades about -0.17 of its total potential returns per unit of risk. Kymera Therapeutics is currently generating about -0.14 per unit of volatility. If you would invest 4,876 in Kymera Therapeutics on August 24, 2024 and sell it today you would lose (471.00) from holding Kymera Therapeutics or give up 9.66% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 95.65% |
| Values | Daily Returns |
Mereo BioPharma Group vs. Kymera Therapeutics
Performance |
| Timeline |
| Mereo BioPharma Group |
| Kymera Therapeutics |
Mereo BioPharma and Kymera Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Mereo BioPharma and Kymera Therapeutics
The main advantage of trading using opposite Mereo BioPharma and Kymera Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Mereo BioPharma position performs unexpectedly, Kymera Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will offset losses from the drop in Kymera Therapeutics' long position.| Mereo BioPharma vs. Terns Pharmaceuticals | Mereo BioPharma vs. PDS Biotechnology Corp | Mereo BioPharma vs. Inozyme Pharma | Mereo BioPharma vs. Hookipa Pharma |
| Kymera Therapeutics vs. Foghorn Therapeutics | Kymera Therapeutics vs. Shattuck Labs | Kymera Therapeutics vs. Monte Rosa Therapeutics | Kymera Therapeutics vs. Nurix Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Complementary Tools
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes |